VolitionRX Ltd
VNRX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.35M
Close$
$1.02
385.5% upside
Current Fair Value
385.5% upsideUndervalued by 385.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.35 Million |
|---|---|
| Enterprise Value | $1.51 Million |
| Earnings per Share | $-4.4 |
| Beta | 1.17 |
| Outstanding Shares | 9,154,815 |
Return
| Return on Equity | 127.90% |
|---|---|
| Return on Assets | -308.88% |
| Return on Invested Capital | -264.57% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | -0.3 |
| Price to Sales | - |
| Price to Book Ratio | -0.07 |
| Enterprise Value to Revenue | 0.61 |
| Enterprise Value to EBIT | 0.11 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.29 |
| Debt to Equity | -0.1 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.71
Consensus analyst estimateRevenue Estimate
$1.63 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.35
Consensus analyst estimateRevenue Estimate
$706,438
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.90%▼ 20.19% |
|---|---|
| Total Invested | $21,321▼ 99.18% |
| Investors Holding | 4▼ 22.00% |
About VolitionRX Ltd
65 employees
Volition is a multi-national epigenetics company developing simple, easy to use, costeffective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients...